Literature DB >> 26024438

Two New Classes of T-Type Calcium Channel Inhibitors with New Chemical Scaffolds from Ganoderma cochlear.

Feng-Jiao Zhou1,2, Yin Nian3, Yongming Yan1,4, Ye Gong3, Qi Luo1,4, Yu Zhang1, Bo Hou1, Zhi-Li Zuo1, Shu-Mei Wang2, He-Hai Jiang3, Jian Yang3,5, Yong-Xian Cheng1.   

Abstract

T-type calcium channel (TTCC) inhibitors hold great potential for the treatment of a variety of neurological disorders. Cochlearoids A-E (1-5), five pairs of dimeric meroterpenoid enantiomers, and cochlearines A (6) and B (7), two pairs of enantiomeric hybrid metabolites, were isolated and characterized from Ganoderma cochlear. Biological evaluation found that compounds (+)-1, (-)-3, and (±)-6 significantly inhibited Cav3.1 TTCC and showed noticeable selectivity against Cav1.2, Cav2.1, Cav2.2, and Kv11.1 (hERG) channels.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26024438     DOI: 10.1021/acs.orglett.5b01353

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  A novel polycyclic meroterpenoid with aldose reductase inhibitory activity from medicinal mushroom Ganoderma leucocontextum.

Authors:  Jinjin Zhang; Ke Ma; Hongyu Chen; Kai Wang; Weiping Xiong; Li Bao; Hongwei Liu
Journal:  J Antibiot (Tokyo)       Date:  2017-05-24       Impact factor: 2.649

Review 2.  Natural Enantiomers: Occurrence, Biogenesis and Biological Properties.

Authors:  Jin-Hai Yu; Zhi-Pu Yu; Robert J Capon; Hua Zhang
Journal:  Molecules       Date:  2022-02-14       Impact factor: 4.411

Review 3.  Meroterpenoids from Ganoderma Species: A Review of Last Five Years.

Authors:  Xingrong Peng; Minghua Qiu
Journal:  Nat Prod Bioprospect       Date:  2018-05-02

4.  Cytotoxic and N-Acetyltransferase Inhibitory Meroterpenoids from Ganoderma cochlear.

Authors:  Li-Zhi Cheng; Fu-Ying Qin; Xiao-Chi Ma; Shu-Mei Wang; Yong-Ming Yan; Yong-Xian Cheng
Journal:  Molecules       Date:  2018-07-20       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.